Anti-cancer and hemostatic Chinese patent drug

Abstract

The invention discloses anti-cancer and hemostatic Chinese patent drug which comprises the following components by weight: 150 to 200 parts of salsola-like inula flower and herb, 100 parts of white atractylodes rhizome, 100 parts of zedoary, 100 parts of Chinese angelica root, 100 parts of psoralea fruit, 100 parts of pinellia tuber, 100 parts of fritillary bulb, 100 parts of asarum sagittarioides, 60 parts of ginseng, 40 parts of American ginseng, 50 parts of astragalus root, 50 parts of white peony root, 30 parts of rhizome of Sichuan lovage, 50 parts of ass-hide glue, 50 parts of bark of chinese cassia tree, 40 parts of Mabuzi, 7 parts of Banmo, 3 parts of arenobufagin and 40 parts of borneol. The Chinese patent drug has the effects that the curative effect is quick, the Chinese patent drug can effectively restrain complications, is broad-spectrum and anti-cancer, safe, reliable, short in course of treatment, and overcomes the problem of the multidrug resistance of cancer cells, patients can not suffer a relapse after being healed, and the Chinese patent drug has the function of improving the medullary hematopoiesis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and relates to an anticancer and hemostatic Chinese patent medicine, in particular to an anticancer and hemostatic Chinese patent medicine containing saxanol. Background technique [0002] According to national statistics in 2006, the death rate due to cancer accounts for the first in the mortality rate in my country, and the death rate due to stroke ranks second, and the incidence of cancer and leukemia is on the rise year by year. While there are 6 to 10 million cancer patients in the world, there are 3 to 4 million in China alone. Most of the patients died after 1 to 2 years of Western medicine surgery, radiotherapy and chemotherapy, resulting in loss of life and wealth, and many families returned to poverty. There are currently 14 types of traditional Chinese medicine anticancer drugs, as well as Mongolian medicine and Tibetan medicine, and American molecular bombs are not ideal. ...

AI Technical Summary

Problems solved by technology

Nearly 40 years of clinical practice have shown that the traditional method of taking medicine 2 to 3 times a day is effective, but the effect is not generally satisfactory. 3 hours, the growth of cancer cells starts; ③Cancer cells can quickly adapt to the new environment, produce multidrug resistance, and stagnate the curative effect

Images